180 Life Sciences Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by 180 Life Sciences Corp. (not Forum Markets Inc.) on February 23, 2023. The registrant is a Delaware corporation headquartered in Palo Alto, California, with common stock (ATNF) and warrants (ATNFW) trading on The NASDAQ Stock Market LLC.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a specific corporate event rather than periodic financial performance.
Material Changes
On February 23, 2023, the Company received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO). This event was announced via a press release incorporated by reference as Exhibit 99.1.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management commentary on future outlook, or specific risk factors beyond the standard disclosure of the patent allowance event.
Investor Verification Checklist
- Verify the specific patent number and scope of the Notice of Allowance referenced in the press release (Exhibit 99.1).
- Confirm the ticker symbols ATNF and ATNFW on NASDAQ for current trading status.
- Review the Company's most recent 10-K or 10-Q for actual financial metrics, as this 8-K contains none.